LAUREN VANDERBURG: Open Payments
NPI 1669907424 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 61 payments from 16 companies in 2025. Trend: 2023 $1,218 · 2024 $1,216 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $194 |
| Lilly USA, LLC | 13 | $179 |
| Novo Nordisk Inc | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Amgen Inc. | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Electromed, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $27 |
| Edwards Lifesciences Corporation | 1 | $24 |
Products named: UBRELVY, MOUNJARO, AIRSUPRA, Kerendia, OTEZLA, JARDIANCE, Ozempic, SMARTVEST.
Industry payments across MS — which companies pay providers there.
